Immune checkpoint inhibitor nivolumab in people with recurrent select rare cns cancers: Results of interim analysis in a heavily pretreated cohort

Authors
Category Primary study
JournalNeuro-Oncology
Year 2021
This article has no abstract
Epistemonikos ID: 1cd91c00f1eaa22d9bbedbdd34a4d72fd2152f23
First added on: Feb 13, 2025